Director Blank buys 288.0K shares at $1.25 (+83.2% to holdings); stock down -37.3% in 90 days amid $-2.0M net loss, cluster buy pattern
Blank Andrew Scott (Director) purchased 288,000 shares at $1.25 on 2025-09-19, increasing holdings by 83.2% to 634,023 shares. This transaction occurs amid deteriorating company fundamentals: latest quarter revenue was $0.00, net income was $-2,049,000.00, and annual revenue growth shows a decline of -87.8%. The stock has fallen -37.3% over the past 90 days and is currently trading -55.1% below its 52-week high of $3.14. Notably, 2 other insiders also bought within the past 14 days, indicating a coordinated cluster buy pattern, while Blank's prior two purchases at BCDA (on 2025-06-30 and 2025-04-23) both generated positive 30-day returns and the earlier trade achieved a 90-day gain of +20.5%. The timing and magnitude of this purchase against both the steep price decline and severe operational headwinds warrant careful assessment of the underlying strategic intent.
Director Blank Andrew Scott purchases 72,289 shares of BCDA at $2.08 for $150.0K; cluster of 3 other insiders also bought within 14 days
Andrew Scott purchased 72,289 shares at $2.08 on 2025-06-30, increasing his holdings by 26.4% and bringing total shares to 346,023. The purchase occurs as BCDA trades at -48.3% from its 52-week high of $4.02, and notably, three other insiders also made purchases within the same 14-day window, indicating coordinated insider accumulation during a depressed price environment. However, the company's fundamentals present significant headwinds: revenue is $0.00 in the latest quarter with annual revenue declining 87.8%, net losses of $2.7M, and a market cap of only $10.8M, suggesting the company is in severe financial distress or transition. Scott's single prior buy at BCDA on 2025-04-23 has not yet yielded a measurable 90-day outcome, leaving no track record of well-timed purchases at this specific ticker to validate the recent accumulation decision.
Director Andrew Scott buys 131,233 shares at $1.90 on 4/23; 5 insiders also bought in past 14 days; stock -67.6% from 52-week high.
Director Andrew Scott purchased 131,233 shares for $249,998.87, doubling his position to 265,957 shares—a 97.4% increase. This purchase occurs amid a cluster of five other insider buys within the past 14 days, suggesting coordinated accumulation activity. The timing is notable given the company's severe financial distress: BCDA reported $0.00 revenue in the latest quarter, a net loss of $1,737,000.00 for the full year, and annual revenue has contracted 87.8% year-over-year. The stock is trading at $1.97, down 67.6% from its 52-week high and -22.8% over the past 30 days, positioning the purchase at a depressed price point relative to recent history.
